NORTHVALE, N.J, Jan. 23, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. (AMEX:ELI), a leading drug delivery, specialty pharmaceutical company focused primarily on producing proprietary abuse resistant, extended release pain compounds, today announced that it has retained The Global Consulting Group as the company’s strategic investor and media relations counsel.
